Heparin desensitisation prior to cardiopulmonary bypass in a patient with alpha-gal allergy

Anaesth Rep. 2022 Dec 16;10(2):e12203. doi: 10.1002/anr3.12203. eCollection 2022 Jul-Dec.

Abstract

This case report describes the implementation of a heparin desensitisation strategy for a patient with confirmed galactose-alpha-1,3-galactose (alpha-gal) allergy, prior to cardiac surgery. We describe the pre-, intra- and postoperative management. We believe this report can enhance the limited data currently in existence on alternative strategies for heparin utilisation in cardiopulmonary bypass in a previously intolerant patient population.

Keywords: cardiopulmonary bypass; desensitisation; heparin.

Publication types

  • Case Reports